4-amino-N'-hydroxy-N-{3-[(methylsulfonyl)amino]propyl}-1,2,5-oxadiazole-3-carboximidamide | 1204669-78-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机磺酸及其衍生物
• 英文名称: 4-amino-N'-hydroxy-N-{3-[(methylsulfonyl)amino]propyl}-1,2,5-oxadiazole-3-carboximidamide
• 英文别名: 4-amino-N-hydroxy-N'-[3-(methanesulfonamido)propyl]-1,2,5-oxadiazole-3-carboximidamide
• CAS: 1204669-78-2
• 化学式: C₇H₁₄N₆O₄S
• 分子量: 278.292
• InChiKey: KSMLFAQEQVDPMC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.4
• 重原子数：
  18
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  164
• 氢给体数：
  4
• 氢受体数：
  9

反应信息

• 作为反应物：
  描述：

  4-amino-N'-hydroxy-N-{3-[(methylsulfonyl)amino]propyl}-1,2,5-oxadiazole-3-carboximidamide 生成 N'-hydroxy-4-({3-[(methylsulfonyl)amino]propyl}amino)-1,2,5-oxadiazole-3-carboximidamide
  参考文献：
  名称：

  1,2,5-OXADIAZOLES AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE

  摘要：

  本发明涉及1,2,5-噁二唑衍生物及其组合物，它们是色胺酸2,3-双氧酶的抑制剂，可用于治疗癌症和其他疾病，并涉及制备此类1,2,5-噁二唑衍生物的过程和中间体。

  公开号：

  US20100015178A1
• 作为产物：
  描述：

  N-(3-aminopropyl)methanesulfonamide hydrochloride 、 (Z)-4-amino-N-hydroxy-1,2,5-oxadiazole-3-carbimidoyl chloride 以19%的产率得到4-amino-N'-hydroxy-N-{3-[(methylsulfonyl)amino]propyl}-1,2,5-oxadiazole-3-carboximidamide
  参考文献：
  名称：

  1,2,5-OXADIAZOLES AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE

  摘要：

  本发明涉及1,2,5-噁二唑衍生物及其组合物，它们是色胺酸2,3-双氧酶的抑制剂，可用于治疗癌症和其他疾病，并涉及制备此类1,2,5-噁二唑衍生物的过程和中间体。

  公开号：

  US20100015178A1

文献信息

• [EN] SYNERGISTIC COMBINATION OF IMMUNOLOGIC INHIBITORS FOR THE TREATMENT OF CANCER<br/>[FR] COMBINAISON SYNERGIQUE D'INHIBITEURS IMMUNOLOGIQUES POUR LE TRAITEMENT DU CANCER
  申请人：UNIV CHICAGO

  公开号：WO2014066834A1

  公开（公告）日：2014-05-01

  In some embodiments, the methods involve the use of a combination of at least two of the following: an inhibitor of indoleamine-2,3-dioxygenase (IDO), an inhibitor of the PD-L1/PD-1 pathway, an inhibitor of CTLA-4, an inhibitor of CD25, or IL-7. The inventors particularly observed a major synergistic effect of combining anti-CTLA-4 with either an IDO inhibitor, with anti-PD-L1 mAb, or with CD-25 depletion. Such combinations have been found to demonstrate a synergistic effect in treating cancer and tumors, for example by reducing tumor size, increasing the percentage of antigen-specific T cells, and increasing T cell function.

  在一些实施方式中，这些方法涉及至少两种以下物质的组合使用：缓解吲哚胺-2,3-二氧化酶（IDO）的抑制剂、PD-L1/PD-1通路的抑制剂、CTLA-4的抑制剂、CD25的抑制剂或IL-7。发明者特别观察到将抗CTLA-4与IDO抑制剂、抗PD-L1单抗或CD-25耗尽结合的主要协同作用。这些组合已被发现在治疗癌症和肿瘤中展现出协同作用，例如通过减小肿瘤大小、增加特异性抗原T细胞的百分比以及增强T细胞功能。
• 1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- Dioxygenase
  申请人：Incyte Corporation

  公开号：US20150190378A1

  公开（公告）日：2015-07-09

  The present invention is directed to 1,2,5-oxadiazole derivatives, and compositions of the same, which are inhibitors of indoleamine 2,3-dioxygenase and are useful in the treatment of cancer and other disorders, and to the processes and intermediates for making such 1,2,5-oxadiazole derivatives.

  本发明涉及1,2,5-噁二唑衍生物及其组合物，其为色胺2,3-二氧化酶抑制剂，可用于治疗癌症和其他疾病，并涉及制备此类1,2,5-噁二唑衍生物的过程和中间体。
• 1,2,5-Oxadiazoles as Inhibitors of Indoleamine 2,3-Dioxygenase
  申请人：Combs Andrew P.

  公开号：US20120058079A1

  公开（公告）日：2012-03-08

  The present invention is directed to 1,2,5-oxadiazole derivatives, and compositions of the same, which are inhibitors of indoleamine 2,3-dioxygenase and are useful in the treatment of cancer and other disorders, and to the processes and intermediates for making such 1,2,5-oxadiazole derivatives.

  本发明涉及1,2,5-噁二唑衍生物及其组合物，它们是吲哚胺2,3-双加氧酶的抑制剂，在癌症和其他疾病的治疗中有用，并涉及制备这种1,2,5-噁二唑衍生物的过程和中间体。
• 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
  申请人：Incyte Corporation

  公开号：US08088803B2

  公开（公告）日：2012-01-03

  The present invention is directed to 1,2,5-oxadiazole derivatives, and compositions of the same, which are inhibitors of indoleamine 2,3-dioxygenase and are useful in the treatment of cancer and other disorders, and to the processes and intermediates for making such 1,2,5-oxadiazole derivatives.

  本发明涉及1,2,5-噁二唑衍生物及其组合物，它们是色胺酸2,3-双加氧酶的抑制剂，并可用于治疗癌症和其他疾病，以及制备这种1,2,5-噁二唑衍生物的过程和中间体。
• 1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3-Dioxygenase
  申请人：Combs Andrew P.

  公开号：US20140023663A1

  公开（公告）日：2014-01-23

  The present invention is directed to 1,2,5-oxadiazole derivatives, and compositions of the same, which are inhibitors of indoleamine 2,3-dioxygenase and are useful in the treatment of cancer and other disorders, and to the processes and intermediates for making such 1,2,5-oxadiazole derivatives.

  本发明涉及1,2,5-噁二唑衍生物及其组合物，其是色胺酸2,3-双加氧酶的抑制剂，并可用于治疗癌症和其他疾病，以及制造此类1,2,5-噁二唑衍生物的过程和中间体。